Company* (Country; Symbol)


Type/Product Area

Terms/Details (Date)

Accelrys Inc. (subsidiary of Pharmacopeia Inc.; ACCL)

IBM Corp.

Accelrys will resell IBM hardware solutions for life science applications

The deal builds on a two- ear relationship between the companies; terms were not disclosed (3/29)

Affymetrix Inc. (AFFX)

IBM Corp.

Collaboration to combine technologies and services to create a system for integrating genomic data with patient data

They plan to work with companies and organizations to promote open standards and new protocols for integrating patient information with genomic and molecular research data (3/30)

Halozyme Therapeutics Inc. (OTC BB:HZYM)

Cook Ob/Gyn Inc., MediCult A/S and MidAtlantic Diagnostics Inc.

The three companies gained nonexclusive global distribution rights to market Cumulase

Terms were not disclosed; Cumulase is a formulation of recombinant human hyaluronidase for preparing oocytes prior to in vitro fertilization (4/26)

MWG Biotech AG* (Germany)

Government Scientific Source Inc.

Government Scientific will distribute MWG products to U.S. federal customers

Terms of the deal were not disclosed (3/31)

Nanosyn Inc.*

Sertanty Inc.

Co-marketing deal to jointly market products developed using their technologies

They will use Sertanty's design tools and Nanosyn's compound library synthesis expertise to develop focused libraries for kinase targets (3/23)

Target Discovery Inc.*

PrecisionMed Inc.

Collaboration to test theories concerning the mechanism of childhood autism

PrecisionMed will collect samples that will be analyzed by Target Discovery; terms were not disclosed (4/6)


* Private companies are indicated with an asterisk.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.

OTC BB = Over-the-Counter Bulletin Board.